CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol.12, no.10, pp.1753-1758, 2014 (SCI-Expanded)
BACKGROUND & AIMS: We investigated the association between interferon lambda 3 (IFNL3) genotype (also known as interleukin 28B) and response to IFN alpha therapy in patients with chronic hepatitis D virus (HDV) infection.